Owens & Minor (NYSE:OMI) issued an update on its FY 2020
Pre-Market earnings guidance on Thursday morning. The company provided earnings per share guidance of 1.75-1.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.08. Owens & Minor also updated its FY20 guidance to $1.75-1.90 EPS.
NYSE:OMI opened at $20.31 on Friday. The stock has a 50 day simple moving average of $15.71 and a 200 day simple moving average of $9.82. Owens & Minor has a 1-year low of $3.63 and a 1-year high of $22.16. The company has a current ratio of 1.63, a quick ratio of 0.76 and a debt-to-equity ratio of 3.21. The stock has a market cap of $1.30 billion, a P/E ratio of -11.74, a PEG ratio of 0.44 and a beta of 0.59.
Owens & Minor (NYSE:OMI) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.19 by $0.01. Owens & Minor had a positive return on equity of 9.31% and a negative net margin of 1.23%. The company had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.92 billion. During the same quarter last year, the company posted $0.10 EPS. The company’s revenue for the quarter was down 23.9% compared to the same quarter last year. As a group, sell-side analysts forecast that Owens & Minor will post 1.1 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be given a dividend of $0.002 per share. The ex-dividend date is Monday, September 14th. This represents a $0.01 dividend on an annualized basis and a yield of 0.04%. Owens & Minor’s dividend payout ratio is currently 1.79%.
Several research analysts have commented on OMI shares. ValuEngine downgraded Owens & Minor from a hold rating to a sell rating in a report on Sunday, August 9th. Robert W. Baird boosted their price objective on Owens & Minor from $21.00 to $34.00 and gave the company an outperform rating in a research note on Thursday. Barclays raised Owens & Minor from an underweight rating to an equal weight rating and set a $20.00 target price for the company in a research report on Friday. BofA Securities raised Owens & Minor from a neutral rating to a buy rating and boosted their price objective for the stock from $8.00 to $12.00 in a report on Tuesday, July 21st. Finally, Credit Suisse Group reduced their target price on Owens & Minor from $17.00 to $16.00 and set a neutral rating for the company in a report on Friday, August 7th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the stock. The company has a consensus rating of Buy and an average price target of $16.79.
About Owens & Minor
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.